Fig. 6
Box plots of median and interquartile range (IQR) p53 and pp53 Ser392 indexes in relation to body location of HSAs. a p53 index. Cutaneous HSAs (median = 74.61%; IQR = 66.97–83.98%) versus visceral HSAs (median = 41.59%; IQR = 26.89–64.87%). b pp53 Ser392 index. Cutaneous HSAs (median = 53.80%; IQR = 0–69.50%) versus visceral HSAs (median = 0%; IQR = 0–22.53%). c p53 index. Visceral HSAs versus stage I/dermal HSAs (median = 82.33%; IQR = 66.97–86.77%) versus stage II/hypodermal (median = 73.06%; IQR = 67.53–82.40%). d pp53 Ser392 index. Visceral HSAs versus stage I/dermal HSAs (median = 65.15%; IQR = 52.78–79.65%) versus stage II/hypodermal HSAs (median = 12.80%; IQR = 0–67.90%). Mann-Whitney U test (a, b), Tukey test (c) and Mann-Whitney pairwise comparisons (d) were applied for statistical analysis